Literature DB >> 15731463

Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells.

Woon Ling Chan1, Nada Pejnovic, Hamish Hamilton, Tze Vun Liew, Dusan Popadic, Alessandro Poggi, Shazia M Khan.   

Abstract

Immune cell infiltration, vascular smooth muscle cell (VSMC) proliferation, and apoptosis are pathological hallmarks of atherosclerosis. The multifocal, chronic, and inflammatory nature of this disease of the cardiovascular system complicates targeted cellular therapy and emphasizes the need to understand the role and interaction of immune cells with VSMCs. We characterized the immune cell subsets present in human atherosclerotic tissue derived from atherosclerotic abdominal aortic aneurysm (AAA) and expanded them to study their interaction with autologous plaque-derived VSMCs in vitro. We show here that apart from T lymphocytes, plaque infiltrates consist of lots of NK cells and significant proportions of NKT cells that express T cell receptor (TCR) alphabeta, CD4, and the NK markers CD56 and CD161. The infiltrates are predominantly IFN-gamma-producing Type 1 lymphoid cells. When cocultured, the T and NKT cells adhere to VSMCs. CD4+ T cells enhance VSMC proliferation. VSMCs in turn enhance CD4+CD161+ NKT but not CD4+ or CD8+ T cell proliferation. CD4+CD161+ NKT cells inhibit VSMC proliferation by inducing apoptosis. Our results suggest that the interactions of Type 1 CD4+ T and CD4+CD161+ NKT cells with VSMCs may regulate VSMC proliferation and death respectively in atherosclerosis and the balance of these interactions could determine plaque stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731463     DOI: 10.1161/01.RES.0000160543.84254.f1

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

Review 1.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Aortic aneurysms: an immune disease with a strong genetic component.

Authors:  Helena Kuivaniemi; Chris D Platsoucas; M David Tilson
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

3.  Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm.

Authors:  C Galle; L Schandené; P Stordeur; Y Peignois; J Ferreira; J-C Wautrecht; J-P Dereume; M Goldman
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 4.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

Review 5.  Natural killer T cells and atherosclerosis: form and function meet pathogenesis.

Authors:  Nicole A Braun; Roman Covarrubias; Amy S Major
Journal:  J Innate Immun       Date:  2010-03-17       Impact factor: 7.349

6.  IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.

Authors:  Aimalie L Hardaway; Izabela Podgorski
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

Review 7.  T cells in atherosclerosis.

Authors:  Kevin Tse; Harley Tse; John Sidney; Alex Sette; Klaus Ley
Journal:  Int Immunol       Date:  2013-11       Impact factor: 4.823

8.  Human Invariant NKT Cells Induce IL-1β Secretion by Peripheral Blood Monocytes via a P2X7-Independent Pathway.

Authors:  Laura E Felley; Akshat Sharma; Erin Theisen; James C Romero-Masters; John-Demian Sauer; Jenny E Gumperz
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

Review 9.  Intensive statin therapy in acute coronary syndromes.

Authors:  Tze Vun Liew; Kausik K Ray
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

10.  Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation.

Authors:  Masood A Khan; Richard M Gallo; Gourapura J Renukaradhya; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.